Wong L L, Cheung A H, Limm W M, Tsai N C
Department of Surgery, John A. Burns School of Medicine, University of Hawaii, Honolulu.
Hawaii Med J. 1994 Mar;53(3):86-9.
The first liver transplant performed in Hawaii was on May 17, 1993 in a patient with end-stage liver disease caused by autoimmune hepatitis. Liver transplantation is a well-accepted treatment for end-stage liver disease with a 1-year patient survival of 80% to 85%. Early recognition of the appropriate candidate by primary care physicians and prompt referral to a liver transplant center are essential for optimal results. The indications, contraindications, organ procurement and allocation, complications, and results of liver transplantation are described. Finally, several controversial areas will be introduced, including liver transplant for alcoholic cirrhosis and hepatitis B, and use of transjugular intrahepatic portosystemic shunts (TIPS).
夏威夷进行的首例肝移植手术于1993年5月17日进行，患者为一名患有自身免疫性肝炎所致终末期肝病的患者。肝移植是治疗终末期肝病的一种广泛接受的疗法，患者1年生存率为80%至85%。初级保健医生尽早识别合适的候选人并迅速转诊至肝移植中心对于取得最佳结果至关重要。本文描述了肝移植的适应证、禁忌证、器官获取与分配、并发症及结果。最后，将介绍几个有争议的领域，包括酒精性肝硬化和乙型肝炎的肝移植，以及经颈静脉肝内门体分流术（TIPS）的应用。
